Lung Cancer
RSSArticles
-
Patient Pool Eligible for Lung Cancer Screening Expands Under Amended Criteria
CMS lowers age, smoking history thresholds.
-
Report: Record Year-Over-Year Decline in Cancer Death Rate
Fewer smokers, better detection and treatment methods credited with saving lives.
-
Delayed Screenings Correlate with More Severe Lung Cancer Malignancies
COVID-19 led to canceled or delayed care in 2020 — with consequences.
-
Mixed News for Lung Health
Deaths from lung cancer are on the decline, while deaths from lung clots are on the rise, according to a pair of new reports.
-
Selpercatinib Capsules (Retevmo)
Selpercatinib should be prescribed to treat metastatic rearranged during transfection (RET) fusion-positive, non-small cell lung cancer and advanced or metastatic RET-mutant medullary thyroid cancer.
-
B Vitamins and Lung Cancer Risk
These researchers investigated the use of supplemental vitamin B6, folate, and B12 and the risk of lung cancer in 77,118 participants in the Vitamins and Lifestyle cohort, finding an increased risk of lung cancer in men, which was exacerbated by smoking.
-
Occurrence of Second Malignancies after Treatment for Hodgkin's Lymphoma: Who's at Fault?
Capitalizing on a large cohort of British patients followed after treatment for Hodgkin's lymphoma, the risk of occurrence of second malignancy was assessed in the context of treatment with chemotherapy alone vs treatment with combined chemotherapy and radiation. -
Incidental Splenic Mass
A 61-year-old female was evaluated for intermittent upper abdominal discomfort. A non-contrast enhanced CT revealed 5x3x4 cm lesion in the spleen that appeared to be cystic. -
Allergy and Brain Tumors: Something to Sneeze At!
There have been reports over the past decade of an interesting inverse association between allergy and glioma. In the current report pooling data from four large cohorts, investigators examined (prediagnostic) immunoglobulin E levels in 169 individuals who were to develop glioma and compared these with levels in 520 matched controls. -
Reduced CNS Metastases in TKI-Treated Renal Cell Carcinoma: Data from a Retrospective Analysis
In an analysis of outcomes for patients treated at M.D. Anderson for metastatic renal cell carcinoma before and since the advent of treatment with tyrosine kinase inhibitors (TKI), the development of brain metastases was shown to be significantly reduced. The authors speculate that TKI treatment is altering the natural history of renal carcinoma.